The prophylactic and therapeutic efficacy of the broadly active antiviral ribonucleoside N-Hydroxycytidine (EIDD-1931) in a mouse model of lethal Ebola virus infection

Document Details

Document Type
Pub Defense Publication
Publication Date
Jan 01, 2023
Source ID
10.1016/j.antiviral.2022.105453

Entities

People

  • Abel De La Rosa
  • Alexander A. Kolykhalov
  • Alexander N. Freiberg
  • George R. Painter
  • Gregory R Bluemling
  • Jason E. Comer
  • Mark Lockwood
  • Michael G. Natchus
  • Sabue Mulangu
  • Shuli Mao
  • Trevor Brasel
  • Wendy Painter

Organizations

  • Defense Threat Reduction Agency
  • National Institute of Allergy and Infectious Diseases
  • National Institutes of Health